Antimicrobial Resistance: A Global Health Crisis

Antimicrobial Resistance: A Global Health Crisis

smh.com.au

Antimicrobial Resistance: A Global Health Crisis

This article examines the growing threat of antimicrobial resistance and proposes innovative funding models to encourage the development of new antibiotics.

English
Australia
HealthScienceAustraliaGlobal HealthHealthcare FundingUnited KingdomAntimicrobial ResistanceAntibioticsPfizer
World Health Organisation (Who)Australian Antimicrobial Resistance Network (Aamrnet)Pfizer Australia And New Zealand
Andrew BowskillAnne Harris
What are the major challenges in combating antimicrobial resistance?
The article primarily discusses the growing threat of antimicrobial resistance (AMR) and the urgent need for new antibiotics.
What innovative funding models are being considered to address the shortage of new antibiotics?
The current funding model for antimicrobial development is unsustainable, leading to a shortage of new antibiotics. The article highlights the need for innovative funding models, like the UK's 'Netflix model', to incentivize research and development.
What is Australia's current approach to tackling antimicrobial resistance, and what changes are being proposed?
Australia is considering adopting a subscription-based funding model, similar to the UK, to encourage the development of new antimicrobials and improve access to life-saving medicines.

Cognitive Concepts

3/5

Framing Bias

The article frames the issue of antimicrobial resistance as an urgent crisis, emphasizing the potential consequences of inaction and highlighting the need for immediate governmental intervention. This framing may unintentionally downplay other aspects of the problem or solutions.

2/5

Language Bias

While the article uses relatively neutral language, the descriptions of the funding crisis and the potential consequences of inaction could be considered emotionally charged, potentially influencing the reader's perception of the urgency of the situation.

3/5

Bias by Omission

The article focuses heavily on the perspectives of Pfizer and the Australian Antimicrobial Resistance Network, potentially neglecting other viewpoints on the issue of antimicrobial resistance. This omission could lead to an incomplete picture of the challenges and potential solutions.

2/5

False Dichotomy

The article presents a somewhat simplistic dichotomy between the current unsustainable funding model and the proposed subscription model, potentially overlooking other potential solutions or complexities in addressing the issue of antibiotic development.

Sustainable Development Goals

Good Health and Well-being Positive
Direct Relevance

The article highlights the critical need for new antibiotics to combat the growing threat of antimicrobial resistance, which directly impacts global health and well-being.